Spots Global Cancer Trial Database for disulfiram
Every month we try and update this database with for disulfiram cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas | NCT05210374 | Relapsed Sarcom... | Disulfiram Copper Gluconat... Liposomal Doxor... | 1 Year - | Case Comprehensive Cancer Center | |
Disulfiram and Cisplatin in Refractory TGCTs. | NCT03950830 | Germ Cell Tumor | Disulfiram | 18 Years - | National Cancer Institute, Slovakia | |
Disulfiram in Recurrent Glioblastoma | NCT02678975 | Glioma Glioblastoma | Disulfiram Copper Alkylating Agen... | 18 Years - | Sahlgrenska University Hospital, Sweden | |
Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer | NCT02671890 | Metastatic Panc... Refractory Mali... Stage IV Pancre... | Chemotherapy Disulfiram Gemcitabine Hyd... Laboratory Biom... | 18 Years - | Mayo Clinic | |
Bioavailability of Disulfiram and Metformin in Glioblastomas | NCT03151772 | Glioblastoma | Disulfiram Metformin | 18 Years - | Sahlgrenska University Hospital, Sweden | |
A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancer | NCT02963051 | Prostate Cancer | Copper Disulfiram Copper gluconat... | 18 Years - | Duke University | |
Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer | NCT02671890 | Metastatic Panc... Refractory Mali... Stage IV Pancre... | Chemotherapy Disulfiram Gemcitabine Hyd... Laboratory Biom... | 18 Years - | Mayo Clinic | |
Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer | NCT03323346 | Breast Neoplasm... Metastatic Brea... | Disulfiram | 18 Years - | The Institute of Molecular and Translational Medicine, Czech Republic | |
Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform | NCT01777919 | Glioblastoma Mu... | Temozolomide Disulfiram Copper | 18 Years - | Olympion Medical Center | |
Disulfiram in Recurrent Glioblastoma | NCT02678975 | Glioma Glioblastoma | Disulfiram Copper Alkylating Agen... | 18 Years - | Sahlgrenska University Hospital, Sweden | |
Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma | NCT02715609 | Glioblastoma Mu... | Disulfiram Copper Gluconat... Surgery Radiation Temozolomide | 18 Years - | Washington University School of Medicine | |
Disulfiram and Cisplatin in Refractory TGCTs. | NCT03950830 | Germ Cell Tumor | Disulfiram | 18 Years - | National Cancer Institute, Slovakia | |
Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme | NCT03363659 | Glioblastoma Glioblastoma Mu... | Disulfiram Copper gluconat... Temozolomide | 18 Years - | Aurora Health Care | |
Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA) | NCT01118741 | Prostate Cancer | Disulfiram | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver | NCT00742911 | Cancer | Disulfiram Copper Gluconat... | 18 Years - | University of Utah | |
Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer. | NCT04265274 | Metastatic Brea... | Disulfiram Vinorelbin Cisplatin Copper | 18 Years - | National Cancer Institute, Slovakia | |
Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver | NCT00742911 | Cancer | Disulfiram Copper Gluconat... | 18 Years - | University of Utah | |
Bioavailability of Disulfiram and Metformin in Glioblastomas | NCT03151772 | Glioblastoma | Disulfiram Metformin | 18 Years - | Sahlgrenska University Hospital, Sweden | |
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas | NCT05210374 | Relapsed Sarcom... | Disulfiram Copper Gluconat... Liposomal Doxor... | 1 Year - | Case Comprehensive Cancer Center | |
Study of Disulfiram and Copper Gluconate in Patients With Treatment-Refractory Multiple Myeloma | NCT04521335 | Multiple Myelom... | Disulfiram Copper Gluconat... | 18 Years - | University of Utah | |
Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform | NCT01777919 | Glioblastoma Mu... | Temozolomide Disulfiram Copper | 18 Years - | Olympion Medical Center | |
A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma | NCT02770378 | Glioblastoma | Temozolomide Aprepitant Minocycline Disulfiram Celecoxib Sertraline Captopril Itraconazole Ritonavir Auranofin | 18 Years - | University of Ulm |